HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An anti-okadaic acid-anti-idiotypic antibody bearing an internal image of okadaic acid inhibits protein phosphatase PP1 and PP2A catalytic activity.

Abstract
Okadaic acid (OA), produced by marine phytoplankton, is the parent compound of a family of marine toxins responsible for diarrheic shellfish poisoning (DSP). A monoclonal antibody to OA (6/50) (Ab1) has been raised and in turn used for immunization of syngeneic animals. Mice inoculated with the 6/50 idiotype produced both anti-idiotypic antibodies (Ab2) and OA binding antibodies (Ab3). The selected anti-idiotypic antibody 1/59 bound to the immunizing 6/50 idiotype but not to F(ab')2 fragments of pooled normal mouse Ig. It inhibited the binding of OA to solid-phase attached F(ab')2 of 6/50 IgG as well as the binding of 6/50 IgG to a solid-phase bound OA. Like OA, 1/59 anti-idiotypic antibody inhibited protein phosphatase 1 and 2A catalytic subunits in a 32P-phosphorylase a phosphatase radioassay. Thus, 1/59 IgG is a novel internal image anti-idiotypic antibody (Ab2 beta) and can serve as a surrogate of OA in biological assays.
AuthorsW S Shestowky, C F Holmes, T Hu, J Marr, J L Wright, J Chin, H M Sikorska
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 192 Issue 1 Pg. 302-10 (Apr 15 1993) ISSN: 0006-291X [Print] United States
PMID8386509 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Anti-Idiotypic
  • Ethers, Cyclic
  • Isoenzymes
  • Okadaic Acid
  • Phosphoprotein Phosphatases
  • Protein Phosphatase 1
Topics
  • Animals
  • Antibodies, Anti-Idiotypic (immunology, metabolism)
  • Catalysis
  • Ethers, Cyclic (immunology)
  • Hybridomas
  • Isoenzymes (antagonists & inhibitors)
  • Mice
  • Okadaic Acid
  • Phosphoprotein Phosphatases (antagonists & inhibitors)
  • Protein Phosphatase 1
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: